Valneva News

Latest Articles

• Pfizer and Valneva’s New Lyme Vaccine Demonstrates Over 70% Efficacy in Landmark Phase 3 Trial

  Published: Apr 10, 2026

  Section: Diseases & Conditions

  Pharmaceutical partners Pfizer and Valneva announced positive topline results from their Phase 3 VALOR trial for the investigational Lyme disease vaccine, LB6V. The candidate showe...

• Pfizer to Seek FDA Approval for Lyme Disease Vaccine Despite Failing Statistical Goals in Late-Stage Trial

  Published: Apr 2, 2026

  Section: Health Technology

  Pharmaceutical giant Pfizer announced it will pursue regulatory approval for its Lyme disease vaccine candidate, even though the shot missed its primary statistical endpoint in a P...